Zurich Cantonal Bank
AVXL icon

Zurich Cantonal Bank’s Anavex Life Sciences AVXL Stock Holding History

Zurich Cantonal Bank’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49 Hold
19
– – ﹤0.01% 2533
2026
Q1 		$58 Buy
+19
New +$82 ﹤0.01% 2525
2025
Q4 		– Sell
-43,815
Closed -$268K – 2653
2025
Q3 		$390K Sell
43,815
-293
-0.7% -$2.97K ﹤0.01% 1873
2025
Q2 		$407K Buy
44,108
+25,316
+135% +$216K ﹤0.01% 1780
2025
Q1 		$161K Buy
18,792
+16,453
+703% +$155K ﹤0.01% 2204
2024
Q4 		$25.1K Sell
2,339
-491
-17% -$3.78K ﹤0.01% 2587
2024
Q3 		$16.1K Sell
2,830
-52
-2% -$300 ﹤0.01% 2605
2024
Q2 		$12.2K Sell
2,882
-25,663
-90% -$104K ﹤0.01% 2612
2024
Q1 		$145K Buy
28,545
+7,874
+38% +$44.3K ﹤0.01% 2219
2023
Q4 		$192K Buy
20,671
+7,298
+55% +$50.2K ﹤0.01% 2097
2023
Q3 		$87.6K Hold
13,373
– – ﹤0.01% 2414
2023
Q2 		$109K Hold
13,373
– – ﹤0.01% 2314
2023
Q1 		$115K Hold
13,373
– – ﹤0.01% 2212
2022
Q4 		$124K Buy
13,373
+3,470
+35% +$37.1K ﹤0.01% 2141
2022
Q3 		$102K Hold
9,903
– – ﹤0.01% 2204
2022
Q2 		$99K Hold
9,903
– – ﹤0.01% 2251
2022
Q1 		$122K Hold
9,903
– – ﹤0.01% 2188
2021
Q4 		$172K Hold
9,903
– – ﹤0.01% 2169
2021
Q3 		$178K Hold
9,903
– – ﹤0.01% 1999
2021
Q2 		$226K Buy
+9,903
New +$147K ﹤0.01% 1727

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Zurich Cantonal Bank's AVXL Position: Q2 2026 in Review

Zurich Cantonal Bank held its Anavex Life Sciences (AVXL) position steady in Q2 2026 at 19 shares worth $49. The position accounts for ﹤0.01% of the portfolio, ranked #2533.

Zurich Cantonal Bank first reported a position in AVXL in Q2 2021 and has held it in 20 quarters since. The position peaked at $407K in Q2 2025. 178 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Zurich Cantonal Bank held 19 shares of Anavex Life Sciences worth $49 as of Q2 2026.
  • Zurich Cantonal Bank left its Anavex Life Sciences share count unchanged in Q2 2026.
  • Anavex Life Sciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2533 holding.
  • Zurich Cantonal Bank first reported a position in Anavex Life Sciences in Q2 2021 and has held it in 20 quarters since.
  • Zurich Cantonal Bank's Anavex Life Sciences position peaked at $407K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.